PURPOSE: To evaluate the new proper orthogonal decomposition (POD) framework for detecting glaucomatous progression from HRT topographies of human subjects and compare it with HRT topographic change analysis (TCA). METHODS: Of 267 eyes of 187 participants with > or =4 retinal tomographic examinations in the University of California, San Diego Diagnostic Innovations in Glaucoma Study (DIGS), 21 eyes were of longitudinally normal subjects and 36 eyes progressed by stereophotographs or visual field-guided progression analysis (progressors). All others were considered nonprogressing (nonprogressors; n = 210 eyes). POD parameters of Euclidean distance (L(2) norm), image Euclidean distance, and correlation were computed, and their area under receiver operating characteristic curves (AUC) in differentiating progressors from nonprogressors and normal subjects were compared to the TCA parameters of the number of superpixels with significant decrease in retinal height (red pixels), size of the largest cluster of red pixels (CSIZE), and CSIZE% of disc size, all within the optic disc margin. RESULTS: AUCs of the best performing POD L(2) norm and TCA red pixel parameters in differentiating progressors from normal subjects were both 0.86 and in differentiating progressors from nonprogressors were 0.68 and 0.64, respectively; the AUC differences were not statistically significant. CONCLUSIONS: The POD framework, which can detect and confirm glaucomatous changes in a single follow-up visit, provides a performance similar to that of TCA in differentiating progressors from normal subjects and nonprogressors.
PURPOSE: To evaluate the new proper orthogonal decomposition (POD) framework for detecting glaucomatous progression from HRT topographies of human subjects and compare it with HRT topographic change analysis (TCA). METHODS: Of 267 eyes of 187 participants with > or =4 retinal tomographic examinations in the University of California, San Diego Diagnostic Innovations in Glaucoma Study (DIGS), 21 eyes were of longitudinally normal subjects and 36 eyes progressed by stereophotographs or visual field-guided progression analysis (progressors). All others were considered nonprogressing (nonprogressors; n = 210 eyes). POD parameters of Euclidean distance (L(2) norm), image Euclidean distance, and correlation were computed, and their area under receiver operating characteristic curves (AUC) in differentiating progressors from nonprogressors and normal subjects were compared to the TCA parameters of the number of superpixels with significant decrease in retinal height (red pixels), size of the largest cluster of red pixels (CSIZE), and CSIZE% of disc size, all within the optic disc margin. RESULTS: AUCs of the best performing POD L(2) norm and TCA red pixel parameters in differentiating progressors from normal subjects were both 0.86 and in differentiating progressors from nonprogressors were 0.68 and 0.64, respectively; the AUC differences were not statistically significant. CONCLUSIONS: The POD framework, which can detect and confirm glaucomatous changes in a single follow-up visit, provides a performance similar to that of TCA in differentiating progressors from normal subjects and nonprogressors.
Authors: Andrew J Patterson; David F Garway-Heath; Nicholas G Strouthidis; David P Crabb Journal: Invest Ophthalmol Vis Sci Date: 2005-05 Impact factor: 4.799
Authors: Christopher Bowd; Madhusudhanan Balasubramanian; Robert N Weinreb; Gianmarco Vizzeri; Luciana M Alencar; Neil O'Leary; Pamela A Sample; Linda M Zangwill Journal: Invest Ophthalmol Vis Sci Date: 2008-10-03 Impact factor: 4.799
Authors: Madhusudhanan Balasubramanian; Stanislav Zabić; Christopher Bowd; Hilary W Thompson; Peter Wolenski; S Sitharama Iyengar; Bijaya B Karki; Linda M Zangwill Journal: IEEE Trans Inf Technol Biomed Date: 2009-04-14
Authors: Madhusudhanan Balasubramanian; David J Kriegman; Christopher Bowd; Michael Holst; Robert N Weinreb; Pamela A Sample; Linda M Zangwill Journal: Invest Ophthalmol Vis Sci Date: 2012-06-14 Impact factor: 4.799
Authors: Madhusudhanan Balasubramanian; Ery Arias-Castro; Felipe A Medeiros; David J Kriegman; Christopher Bowd; Robert N Weinreb; Michael Holst; Pamela A Sample; Linda M Zangwill Journal: Invest Ophthalmol Vis Sci Date: 2014-03-19 Impact factor: 4.799
Authors: D Kourkoutas; Y M Buys; J G Flanagan; N Karamaounas; G Georgopoulos; E Iliakis; M M Moschos; G E Trope Journal: J Ophthalmol Date: 2014-01-21 Impact factor: 1.909